Study summary

A multicenter, randomized, double-blind, placebo-controlled, phase 2 study of Erlotinib (Tarceva®) in combination with OSI-906 in Patients with Advanced non-small cell lung cancer (NSCLC) with Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene who are Chemonaive.

Additional Study Details

Phase
2
Product
  • OSI-906
  • Erlotinib
  • Placebo
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    88
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for Study of Erlotinib (Tarceva®) in combination with OSI-906 in Patients with Advanced non-small cell lung cancer (NSCLC) with Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Withdrawn
      Providence St. Joseph Medical Center
      Burbank, California, United States, 91505
      Withdrawn
      Chao Family Comprehensive Cancer Center - University California
      Irvine, California, United States, 92868
      Completed
      Cleveland Clinic Florida
      Weston, FL, United States, 33331
      Completed
      Asan Medical Center
      Songpa-gu, Seoul, Republic of Korea, 138736
      Completed
      Chonnam National University Hwasun Hospital
      Ilsimri, Hwasun-gun, Republic of Korea, 519809
      Completed
      Swedish Cancer Institute
      Seattle, Washington, United States, 98104
      Completed
      Memorial Sloan Kettering Cancer Center
      New York, New York, United States, 10021
      Completed
      University of Tennessee Cancer Institute
      Memphis, Tennessee, United States, 31804
      Completed
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
      Baltimore, Maryland, United States, 21231
      Completed
      Johns Hopkins Singapore International Medical Centre
      Singapore, Singapore, 308433
      Withdrawn
      Hematology Oncology Associates of the Treasure Coast
      Port St. Lucie, Florida, United States, 34952
      Completed
      National Cancer Institute
      Phayathai, Bangkok, Thailand, 10400
      Completed
      Rush University Medical Center
      Chicago, IL, United States, 60612
      Completed
      University of California, San Diego/Moores Cancer Center
      La Jolla, CA, United States, 92093
      Completed
      Juravinski Cancer Centre
      Hamilton, Ontario, Canada, L8V 5C2
      Withdrawn
      Mount Elizabeth Medical Centre
      Singapore, Singapore, 228510
      Completed
      Karmanos Cancer Institute
      Detroit, Michigan, United States, 48201
      Completed
      London Regional Cancer Program
      London, Ontario, Canada, N6A 4L6
      Completed
      Korea University Anam Hospital
      Seoul, Republic of Korea, 136705
      Completed
      Medical University of South Carolina
      Charleston, South Carolina, United States, 29425
      Completed
      Songklanagarind Hospital, Prince of Songkla University
      Songkla, Thailand, 90110
      Withdrawn
      Pacific Cancer Medical Center
      Anaheim, California, United States, 92801
      Completed
      Seoul National University Bundang Hospital
      Seongnam-si, Republic of Korea, 463-707
      Withdrawn
      Bumrungrad Hospital Public Company, Ltd. Clinical Research Center
      Bangkok, Thailand, 10110
      Completed
      Oncocare Cancer Center
      Singapore, Singapore, 258499
      Withdrawn
      Inha University Hospital
      Inchon, Republic of Korea, 400711
      Completed
      Vanderbilt University Medical Center
      Nashville, Tennessee, United States, 37232
      Completed
      Samsung Medical Center
      Seoul, Republic of Korea, 135710
      Completed
      Princess Margaret Hospital
      Toronto, Ontario, Canada, M5G 2M9
      Withdrawn
      Queen Mary Hospital
      Pokfulam, Hong Kong, Hong Kong
      Completed
      Pamela Youde Nethersole Eastern Hospital
      Chai Wan, Hong Kong, 852
      Withdrawn
      Monrefiore Medical Center
      Bronx, NY, United States, 10467
      Completed
      Khon Kaen University
      Khon Kaen, Thailand, 40002
      Withdrawn
      University Hospitals of Clevelnd
      Cleveland, Ohio, United States, 44106
      Completed
      Seattle Cancer Care Alliance University of Washington
      Seattle, Washington, United States, 98109
      Completed
      Jewish General Hospital
      Montreal, Quebec, Canada, H3T 1E2
      Withdrawn
      Gachon University Gil Medical Center
      Incheon, Republic of Korea, 405760
      Completed
      Maharaj Nakorn Chiangmai
      Chiang Mai, Thailand, 50002
      Completed
      H. Lee Moffitt Cancer Center and Research Institute
      Tampa, Florida, United States, 33612
      Completed
      Northwestern Memorial Hospital
      Chicago, IL, United States, 60611

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?